Blueprint Medicines Historical PE Ratio image   This BPMC PE ratio history page last updated 3/11/2024
Blueprint Medicines Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/15/2024
87.57-1.82-7.28NA
Q3 2023
10/26/2023
55.22-2.20-8.80NA
Q2 2023
8/2/2023
54.30-2.19-8.76NA
Q1 2023
5/4/2023
58.41-2.15-8.60NA
Q4 2022
2/16/2023
44.71-2.65-10.60NA
Q3 2022
11/1/2022
48.24-2.23-8.92NA
Q2 2022
8/2/2022
56.29-2.68-10.72NA
Q1 2022
5/3/2022
62.82-1.79-7.16NA
Q4 2021
2/16/2022
74.89-0.99-3.96NA
Q3 2021
10/28/2021
113.33-2.00-8.00NA
Q2 2021
7/29/2021
84.74-1.86-7.44NA
Q1 2021
4/29/2021
98.87-1.72-6.88NA
Q4 2020
2/17/2021
100.25-1.53-6.12NA
Q3 2020
10/29/2020
106.8411.1644.642.4
Q2 2020
7/30/2020
73.89-2.28-9.12NA
Q1 2020
5/6/2020
58.97-2.11-8.44NA
Q4 2019
2/13/2020
63.81-1.35-5.40NA
Q3 2019
11/5/2019
70.50-1.93-7.72NA
Q2 2019
8/1/2019
93.82-2.04-8.16NA
Q1 2019
5/9/2019
82.30-1.98-7.92NA
Q4 2018
2/26/2019
76.42-1.83-7.32NA
Q3 2018
10/30/2018
60.80-1.66-6.64NA
Q2 2018
8/1/2018
66.79-0.62-2.48NA
Q1 2018
5/2/2018
83.06-1.29-5.16NA
Q4 2017
2/21/2018
87.49-1.23-4.92NA
Q3 2017
10/31/2017
66.42-0.96-3.84NA
Q2 2017
8/2/2017
49.29-0.86-3.44NA
Q1 2017
5/3/2017
43.81-0.84-3.36NA
Q4 2016
3/9/2017
36.23-0.75-3.00NA
Q3 2016
11/10/2016
33.19-0.62-2.48NA
Q2 2016
8/9/2016
23.76-0.70-2.80NA
Q1 2016
5/10/2016
15.36-0.57-2.28NA
Q4 2015
3/11/2016
17.00-0.58-2.32NA
Q3 2015
11/9/2015
22.82-0.47-1.88NA
Q2 2015
8/10/2015
26.98-0.81-3.24NA
Q1 2015
6/11/2015
33.16-7.76-31.04NA
Blueprint Medicines PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/15/2024
87.57-1.82-8.36NA
Q3 2023
10/26/2023
55.22-2.20-9.19NA
Q2 2023
8/2/2023
54.30-2.19-9.22NA
Q1 2023
5/4/2023
58.41-2.15-9.71NA
Q4 2022
2/16/2023
44.71-2.65-9.35NA
Q3 2022
11/1/2022
48.24-2.23-7.69NA
Q2 2022
8/2/2022
56.29-2.68-7.46NA
Q1 2022
5/3/2022
62.82-1.79-6.64NA
Q4 2021
2/16/2022
74.89-0.99-6.57NA
Q3 2021
10/28/2021
113.33-2.00-7.11NA
Q2 2021
7/29/2021
84.74-1.866.0514.0
Q1 2021
4/29/2021
98.87-1.725.6317.6
Q4 2020
2/17/2021
100.25-1.535.2419.1
Q3 2020
10/29/2020
106.8411.165.4219.7
Q2 2020
7/30/2020
73.89-2.28-7.67NA
Q1 2020
5/6/2020
58.97-2.11-7.43NA
Q4 2019
2/13/2020
63.81-1.35-7.30NA
Q3 2019
11/5/2019
70.50-1.93-7.78NA
Q2 2019
8/1/2019
93.82-2.04-7.51NA
Q1 2019
5/9/2019
82.30-1.98-6.09NA
Q4 2018
2/26/2019
76.42-1.83-5.40NA
Q3 2018
10/30/2018
60.80-1.66-4.80NA
Q2 2018
8/1/2018
66.79-0.62-4.10NA
Q1 2018
5/2/2018
83.06-1.29-4.34NA
Q4 2017
2/21/2018
87.49-1.23-3.89NA
Q3 2017
10/31/2017
66.42-0.96-3.41NA
Q2 2017
8/2/2017
49.29-0.86-3.07NA
Q1 2017
5/3/2017
43.81-0.84-2.91NA
Q4 2016
3/9/2017
36.23-0.75-2.64NA
Q3 2016
11/10/2016
33.19-0.62-2.47NA
Q2 2016
8/9/2016
23.76-0.70-2.32NA
Q1 2016
5/10/2016
15.36-0.57-2.43NA
Q4 2015
3/11/2016
17.00-0.58-9.62NA
Q3 2015
11/9/2015
22.82-0.47NANA
Q2 2015
8/10/2015
26.98-0.81NANA
Q1 2015
6/11/2015
33.16-7.76NANA
Quotes delayed 20 minutes

Email EnvelopeFree BPMC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Blueprint Medicines (BPMC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BPTH PE Ratio History
BRKR PE Ratio History
BRTX PE Ratio History
BSGM PE Ratio History
BSX PE Ratio History
BTAI PE Ratio History
BTCY PE Ratio History
BTX PE Ratio History
BVS PE Ratio History
BWV PE Ratio History
How should the BPMC historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Blueprint Medicines. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BPMC Historical PE Ratio page.

What is the average historical PE for BPMC based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BPMC historical PE ratio using the annualized quarterly earnings method works out to 2.4.

What is the average historical PE for BPMC based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BPMC historical PE ratio using the TTM earnings method works out to 17.6.

On this page we presented the Blueprint Medicines Historical PE Ratio information for Blueprint Medicines' stock. The average BPMC historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BPMC historical PE based on this TTM earnings result method is 17.6. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BPMC historical PE result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for BPMC had been 92.30, and the most recent quarterly earnings result, annualized, was 44.64. Meanwhile, the most recent TTM earnings summed to 6.05. From these numbers, we calculate the recent BPMC PE on 3/8/2024 based on annualized quarterly EPS was 2.1. Based on BPMC's history, that recent PE is low relative to the historical average, with the recent PE 12.5% lower than the historical average PE across our data set for Blueprint Medicines. Looking at the recent BPMC PE on 3/8/2024 based on TTM EPS, we calculate the ratio at 15.3. Based on BPMC's history, that recent PE is low relative to the historical average, with the recent PE 13.1% lower than the average PE across our Blueprint Medicines data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on BPMC or any other given stock, valuation analysis for BPMC can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Blueprint Medicines PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BPMC. Thanks for visiting, and the next time you need to research BPMC Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CSGS shares outstanding history, NWL market cap history, PHIO Insider Buying.

 

Blueprint Medicines Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.